A new concept for 'starting menopause hormone therapy' using an oral GnRH antagonist with an estrogen and a progestin (or an estrogen and a selective estrogen receptor modulator): why must we wait to treat women in perimenopause?
Listen to this summary
This proof-of-concept paper proposes a "starting menopause hormone therapy" (sMHT) approach that uses an oral GnRH antagonist combined with an estrogen and a progestin (or a SERM) to treat vasomotor symptoms and abnormal uterine bleeding as soon as they appear in perimenopause, rather than waiting for 12 months of amenorrhea. The authors ask whether the availability of oral GnRH antagonists makes it possible to start hormone treatment earlier in symptomatic perimenopausal women, avoiding the safety and adherence drawbacks of combined oral contraceptives or sequential estro-progestin regimens. They suggest that sMHT could later transition to conventional MHT once ovarian function has definitively ceased.
This is one of 33,000+ journals available on OSLR. Try it free for 14 days.
Free 14-day trial. 33,000+ journals. Cancel anytime.

More from Climacteric : the journal of the International Menopause Society
View all →Nov 19, 2026 · Climacteric : the journal of the International Menopause Society
GESS-AEEM consensus on testosterone therapy in women: a clinical implementation framework.
Nov 17, 2026 · Climacteric : the journal of the International Menopause Society
Dry eye disease in the menopausal transition: toward recognition as a hormonal manifestation.
Nov 16, 2026 · Climacteric : the journal of the International Menopause Society
Intracrinology and tissue-selective effects of tibolone: mechanisms and implications.
Nov 13, 2026 · Climacteric : the journal of the International Menopause Society
The breast at perimenopause.
Nov 11, 2026 · Climacteric : the journal of the International Menopause Society
Mindfulness-based stress reduction for sleep quality and emotional state in menopause-related insomnia symptoms.
Nov 9, 2026 · Climacteric : the journal of the International Menopause Society
Challenges in perimenopause research and the application of existing criteria for staging reproductive aging in low and middle-income countries: a scoping review.
More in Obstetrics & Gynecology
View all →Nov 20, 2026 · Reproductive biology and endocrinology : RB&E
Sirtuin 1-dependent oleanolic acid protection attenuates oxidative stress-induced granulosa cell dysfunction and ovarian damage.
Nov 20, 2026 · BMC women's health
HDAC2/Parkin axis regulates mitochondrial dysfunction and mitophagy in polyendocrine metabolic ovarian syndrome.
Nov 20, 2026 · BMC women's health
Long-term risk of second primary malignancies and symptomatic heart failure after pegylated liposomal doxorubicin versus conventional anthracycline-based chemotherapy in early-stage breast cancer survivors: a single-center experience.
Nov 20, 2026 · BMC women's health
Association between internet use and unmet need for family planning among currently pregnant women in Bangladesh: evidence from BDHS 2022.
Nov 20, 2026 · Journal of pain and symptom management
Perceived Clinical Utility of a Routine Family Experience Feedback Loop in Pediatric Palliative Care.
Nov 20, 2026 · Journal of pain and symptom management
Predictors of Clinician Success, Quality, and Resilience in Outpatient Pediatric Palliative Care.
"Oslr has become part of my weekly routine on my day off. The clinical relevance of the summaries is outstanding — I'd rate it 9/10. Being able to consume research hands-free is a huge advantage for busy physicians."
Dr. Jennifer Thompson
Portland, OR


